Two Sigma Investments
THRX

Two Sigma Investments’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Two Sigma Investments’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,112
Closed -$57.2K – 3496
2023
Q4 		$57.2K Sell
14,112
-8,539
-38% -$26.1K ﹤0.01% 2986
2023
Q3 		$60.9K Sell
22,651
-29,150
-56% -$114K ﹤0.01% 2796
2023
Q2 		$483K Sell
51,801
-22,288
-30% -$220K ﹤0.01% 2347
2023
Q1 		$658K Buy
74,089
+56,914
+331% +$559K ﹤0.01% 2080
2022
Q4 		$85.5K Buy
+17,175
New +$101K ﹤0.01% 2528

Two Sigma Investments's THRX Position: Q1 2024 in Review

Two Sigma Investments sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 14,112 shares — an estimated $57.2K sold.

Two Sigma Investments first reported a position in THRX in Q4 2022 and held it in 5 quarters. The position peaked at $658K in Q1 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • Two Sigma Investments reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 14,112 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $57.2K.
  • Two Sigma Investments first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Two Sigma Investments's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $658K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.